Complete Response Letter

[FDA] A written communication to an applicant from FDA usually describing all of the deficiencies that the agency has identified in an application or abbreviated application that must be satisfactorily addressed before it can be approved. NOTE: The use of the Complete Response Letter discontinues FDA’s use of approvable letters and not approvable letters when taking action on marketing applications.

Source: 21 CFR 314.3(b)


Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.